Medolla, Italy

Mauro Suffritti

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in Extracorporeal Blood Treatment. Top assignees: Gambro Lundia Ab, Baxter Healthcare Sa, Baxter International Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauro Suffritti. Retrieved from https://idiyas.com/inventor/mauro-suffritti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Extracorporeal Blood Treatment
Peritoneal Dialysis
Dialysis System
Blood Circuit
Filter Testing
Peristaltic Pump
Ultrafilter Membrane
Blood Line Monitoring
Manifold Assembly
Testing Filters
Hemodialysis
Mobile Cart
23 patents (USPTO):Explore Patents

Title: Mauro Suffritti: Innovator in Extracorporeal Blood Treatment Technologies

Introduction

Mauro Suffritti is an accomplished inventor based in Medolla, Italy, with a remarkable portfolio of 15 patents to his name. His innovative contributions primarily focus on advancements in the field of medical technology, particularly concerning blood treatment processes.

Latest Patents

Among his latest inventions are two significant patents that enhance the functionality and efficacy of blood treatment equipment. The first is an **Apparatus and Method for Testing Integrity of an Ultrafilter Membrane**, which introduces an advanced apparatus for extracorporeal blood treatment. This device is equipped with a supply line, a waste line, and an ultrafilter. The system also features an air inlet line and a pressure sensor designed to detect pressure in the waste line, along with a controller that conducts integrity tests on the ultrafilter membrane to identify fiber breaks.

The second notable patent is an **Apparatus for Extracorporeal Blood Treatment**, which consists of a treatment unit divided into two chambers by a semipermeable membrane. This setup includes a blood removal line, a blood return line, an infusion line for replacement fluid, and a fluid evacuation line. A regulating device actively manages transmembrane pressure, with a control unit that adjusts parameters based on real-time measurements, ensuring optimal performance of the treatment apparatus.

Career Highlights

Mauro has had a notable career, during which he has made significant strides in medical technology. His experience encompasses key roles in esteemed organizations, including **Gambro Lundia AB** and **Magneti Marelli Powertrain S.p.A.**. Through these roles, he has honed his expertise and contributed to the development of innovative medical solutions.

Collaborations

Throughout his career, Mauro has collaborated with various talented professionals, including colleagues such as Anna Puppini and Massimo Fava. These collaborations have undoubtedly played a crucial role in advancing his inventive endeavors and enhancing the impact of his work in the medical technology field.

Conclusion

Mauro Suffritti stands out as a notable figure in the realm of medical innovations. His extensive patent portfolio and continued commitment to enhancing medical treatment technologies reflect his dedication to improving patient care. As he moves forward in his career, his contributions are expected to inspire further advancements in the field of extracorporeal blood treatment and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…